Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
  1. 4 Open-market sale SVP, Head of Global Commercial sold 1,544 shares at $40.15 ($61,992)
  2. 4 Grant or award Global Head of R&D acquired 50,000 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale Chief Executive Officer sold 8,800 shares at an average $42.46 ($373,659)
  5. 4 Open-market sale Chief Executive Officer sold 8,800 shares at an average $41.87 ($368,472)
  6. 4 Grant or award Senior VP & General Counsel acquired 42,500 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Shares withheld for taxes Chief Tech. Operations Officer gave up 642 shares (to pay taxes)
  9. 4/A Open-market sale Chief Executive Officer sold 200 shares at $38.40 ($7,680)
  10. 4 Open-market sale EVP & Chief R & QA Officer sold 22,400 shares at $40.07 ($897,568)
  11. 4 Open-market sale EVP & Chief R & QA Officer sold 100,203 shares at an average $37.87 ($3,795,062)
  12. 4 Open-market sale Chief Executive Officer sold 8,800 shares at an average $38.59 ($339,549)
  13. 4 Open-market sale EVP, R&D & Chief Scientific Of sold 18,327 shares at an average $39.79 ($729,265)
  14. 4 Open-market sale EVP & Chief Financial Officer sold 6,000 shares at an average $40.41 ($242,460)
  15. 4 Open-market sale Chief Executive Officer sold 8,800 shares at an average $42.13 ($370,748)
  16. 4 Open-market sale Chief Executive Officer sold 1,000 shares at an average $46.31 ($46,314)
  17. 4 Open-market sale Chief Executive Officer sold 17,800 shares at an average $44.65 ($794,733)
  18. 4 Open-market sale Director sold 1,183 shares at $46.50 ($55,010)
  19. 4 Exercise or conversion Director acquired 1,603 shares (option exercise)
  20. 4 Exercise or conversion EVP, R&D & Chief Scientific Of acquired 553 shares (option exercise)

Page 18 of 33 · 645 filings